Nurses’ Perception of Using Cognitive Behavior Therapy for Death Anxiety and Ageism

2021 ◽  
pp. 003022282110467
Author(s):  
Mohammad Rababa ◽  
Sami Al-Rawashdeh ◽  
Imteyaz El Jarrah ◽  
Abdallah Abu Khait
Keyword(s):  
Clinical Practice ◽  
Comparative Study ◽  
Treatment Adherence ◽  
Behavior Therapy ◽  
Cognitive Behavior Therapy ◽  
Death Anxiety ◽  
Cognitive Behavior ◽  
Jordanian Nurses ◽  
Promising Avenue

Despite the effectiveness of cognitive behavior therapy (CBT) in relieving death anxiety and ageism among nurses, there is not a complete consensus on its acceptability, adherence, credibility, and expectancy in the literature. Therefore, this descriptive-comparative study aimed to examine Jordanian nurses’ perception of using CBT in relieving death anxiety and ageism. Most participants perceived CBT as a credible and adherable treatment for death anxiety and ageism. Significant differences were found in the CBT credibility and expectancy between nurses grouped according to levels of perceived treatment adherence and acceptability of CBT. The findings provide a promising avenue for adopting CBT to target death anxiety and its associated ageism among nurses and for improving CBT adherence, acceptability, credibility, and expectancy. A better understanding of participants’ perception of CBT is crucial for optimal clinical practice.

scholarly journals O9.8. USING APPROPRIATE OUTCOMES WHEN EVALUATING COGNITIVE BEHAVIOR THERAPY FOR PSYCHOSIS (CBTP) FOR PATIENTS WITH SCHIZOPHRENIA IN AN INPATIENT SETTING: TRENDS OBSERVED IN CLINICAL PRACTICE

2019 ◽  
Vol 45 (Supplement_2) ◽  
pp. S189-S190
Author(s):  
Heather Adams ◽  
Gopal Vyas ◽  
Jerome Kowalewski ◽  
Christopher Kitchen ◽  
Charles Richardson ◽  
...  
Keyword(s):  
Clinical Practice ◽  
Behavior Therapy ◽  
Cognitive Behavior Therapy ◽  
Inpatient Setting ◽  
Cognitive Behavior

Neuroscience-Informed Cognitive-Behavior Therapy in Clinical Practice: A Preliminary Study

2016 ◽  
Vol 38 (2) ◽  
pp. 139-154 ◽  
Author(s):  
Thomas A. Field ◽  
Eric T. Beeson ◽  
Laura K. Jones
Keyword(s):  
Mental Health ◽  
Clinical Practice ◽  
Behavior Therapy ◽  
Cognitive Behavior Therapy ◽  
Depressive Disorders ◽  
Behavioral Therapy ◽  
Mental Health Counseling ◽  
Cognitive Behavior ◽  
Health Counseling ◽  
Conventional Models

The field of neuroscience has influenced revisions to conventional models of cognitive behavioral therapy (CBT). In the mental health counseling field, a conceptual model of neuroscience-informed cognitive-behavior therapy (n-CBT) was first published in the Journal of Mental Health Counseling in 2015. The present article reviews findings from the first six months of a year-long pilot study that examined counselor and client use and perceptions of n-CBT following application in clinical practice settings. Counselors reported successful alleviation of client symptomatology with n-CBT, particularly anxiety and depressive disorders. Counselors and clients also held similar and consistently high perceptions of n-CBT's credibility and the likelihood of improvement when using the model.

What is the minimal dose of cognitive behavior therapy for psychosis? An approximation using repeated assessments over 45 sessions

2016 ◽  
Vol 38 ◽  
pp. 31-39 ◽  
Author(s):  
T.M. Lincoln ◽  
E. Jung ◽  
M. Wiesjahn ◽  
B. Schlier
Keyword(s):  
Clinical Practice ◽  
Behavior Therapy ◽  
Cognitive Behavior Therapy ◽  
Negative Symptoms ◽  
Optimal Dose ◽  
Symptom Distress ◽  
Psychotic Symptoms ◽  
Symptom Improvement ◽  
Cognitive Behavior ◽  
And Coping

AbstractBackgroundThe general efficacy of cognitive behavior therapy for psychosis (CBTp) is well established. Although guidelines recommend that CBTp should be offered over a minimum of 16 sessions, the minimal number of sessions required to achieve significant changes in psychopathology has not been systematically investigated. Empirically informed knowledge of the minimal and optimal dose of CBTp is relevant in terms of dissemination and cost-effectiveness.MethodsWe approached the question of what constitutes an appropriate dose by investigating the dose (duration of CBTp) × response (symptomatic improvement) relationship for positive symptoms, negative symptoms and depression. Patients with psychotic disorders (n = 58) were assessed over the course of 45 sessions of CBTp in a clinical practice setting. At baseline and after session 5, 15, 25, and 45, general psychopathology, psychotic symptoms, symptom distress and coping were assessed with self-report questionnaires. Additionally, individually defined target symptoms and coping were assessed after each session.ResultsSignificant symptom improvement and reduction of symptom distress took place by session 15, and stayed fairly stable thereafter. The frequency of positive and negative symptoms reached a minimum by session 25.ConclusionsOur findings support recommendations to provide CBTp over a minimum of 16 sessions and indicate that these recommendations are generalizable to clinical practice settings. However, the findings also imply that 25 sessions are the more appropriate dose. This study contributes to an empirically informed discussion on the minimal and optimal dose of CBTp. It also provides a basis for planning randomized trials comparing briefer and longer versions of CBTp.

Sign in / Sign up

Export Citation Format

Share Document